Wenzhen Ding
Papers
1
Total Citations
8
H-Index
1
About
Wenzhen Ding is a clinician-researcher whose work focuses on advancing minimally invasive treatments for hepatocellular carcinoma (HCC), particularly through the comparative evaluation of percutaneous microwave ablation and robotic-assisted surgery. In a landmark real-world single-center study published in 2021, Ding directly compared the efficacy and safety of these two cutting-edge approaches for early-stage HCC, providing critical evidence to guide treatment selection. This work, which has garnered 8 citations, addresses a pressing clinical need by offering insights into outcomes such as recurrence rates, complication profiles, and long-term survival. Ding’s research sits at the intersection of interventional oncology and surgical innovation, helping to refine personalized treatment algorithms for liver cancer patients. By systematically analyzing real-world data rather than idealized trial conditions, Ding’s contributions offer practical, actionable knowledge for hepatobiliary surgeons and interventional radiologists. This study has become a reference point for centers adopting robotic hepatectomy or microwave ablation, underscoring Ding’s role in shaping evidence-based practice in liver cancer management.
Research Focus
Key Achievements
Top Papers
- 1